AAP
Ardsley Advisory Partners Portfolio holdings
AUM
$612M
This Quarter Return
-18.18%
1 Year Return
+36.74%
3 Year Return
+173.74%
5 Year Return
+333.08%
10 Year Return
+727.51%
AUM
$373M
AUM Growth
+$373M
(-32%)
Cap. Flow
-$96.4M
Cap. Flow
% of AUM
-25.85%
Top 10 Holdings %
Top 10 Hldgs %
46.98%
Holding
176
New
32
Increased
26
Reduced
23
Closed
71
Top Buys
| 1 |
CVS Health
CVS
|
$12.8M |
| 2 |
CELG
Celgene Corp
CELG
|
$9.35M |
| 3 |
ZEN
ZENDESK INC
ZEN
|
$8.66M |
| 4 |
AQUA
Evoqua Water Technologies Corp. Common Stock
AQUA
|
$7.55M |
| 5 |
TLND
Talend S.A. American Depositary Shares
TLND
|
$7.5M |
Top Sells
| 1 |
Marathon Petroleum
MPC
|
$27M |
| 2 |
Knight Transportation
KNX
|
$17.2M |
| 3 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$15.8M |
| 4 |
Magnolia Oil & Gas
MGY
|
$14.6M |
| 5 |
ADMS
Adamas Pharmaceuticals, Inc.
ADMS
|
$10.2M |
Sector Composition
| 1 | Technology | 32.17% |
| 2 | Healthcare | 22% |
| 3 | Industrials | 12.66% |
| 4 | Utilities | 10.81% |
| 5 | Consumer Staples | 5.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Stryker
SYK
$149B
| $706K | 0.18% |
+4,500
| New | +$706K |
|
|
QTNT
52
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $673K | 0.17% |
110,000
| – | – |
|
|
COUP
53
DELISTED
Coupa Software Incorporated
COUP
| $629K | 0.16% |
+10,000
| New | +$629K |
|
54
Novartis
NVS
$248B
| $601K | 0.15% |
+7,000
| New | +$601K |
|
55
GDS Holdings
GDS
$6.54B
| $577K | 0.15% |
+25,000
| New | +$577K |
|
56
Becton Dickinson
BDX
$54.3B
| $563K | 0.14% |
+2,500
| New | +$563K |
|
|
VTNR
57
DELISTED
Vertex Energy, Inc
VTNR
| $499K | 0.13% |
492,306
+42,893
| +10% | +$43.5K |
|
58
HCA Healthcare
HCA
$95.4B
| $497K | 0.12% |
+4,000
| New | +$497K |
|
59
Zscaler
ZS
$42.1B
| $471K | 0.12% |
+12,000
| New | +$471K |
|
|
MLNX
60
DELISTED
Mellanox Technologies, Ltd.
MLNX
| $462K | 0.12% |
+5,000
| New | +$462K |
|
61
AtriCure
ATRC
$1.73B
| $459K | 0.12% |
15,000
| – | – |
|
62
Merck
MRK
$210B
| $458K | 0.12% |
6,000
-1,500
| -20% | -$115K |
|
63
Viavi Solutions
VIAV
$2.57B
| $452K | 0.11% |
45,000
-20,000
| -31% | -$201K |
|
64
Aldeyra Therapeutics
ALDX
$350M
| $432K | 0.11% |
52,100
-2,900
| -5% | -$24K |
|
65
Harrow
HROW
$1.38B
| $427K | 0.11% |
75,000
-25,000
| -25% | -$142K |
|
|
NVTR
66
DELISTED
Nuvectra Corporation Common Stock
NVTR
| $410K | 0.1% |
25,095
| – | – |
|
67
Cerus
CERS
$251M
| $406K | 0.1% |
80,000
| – | – |
|
|
ACER
68
DELISTED
Acer Therapeutics Inc. Common Stock (DE)
ACER
| $402K | 0.1% |
20,000
| – | – |
|
69
Abbott
ABT
$230B
| $361K | 0.09% |
+5,000
| New | +$361K |
|
70
Option Care Health
OPCH
$4.7B
| $357K | 0.09% |
100,000
+25,000
| +33% | +$89.3K |
|
|
TWTR
71
DELISTED
Twitter, Inc.
TWTR
| $345K | 0.09% |
+12,000
| New | +$345K |
|
72
Lumentum
LITE
$9.37B
| $336K | 0.08% |
8,000
-117,000
| -94% | -$4.91M |
|
73
Vertex Pharmaceuticals
VRTX
$102B
| $331K | 0.08% |
2,000
-4,000
| -67% | -$662K |
|
74
SPDR S&P Biotech ETF
XBI
$5.29B
| $323K | 0.08% |
4,500
-2,500
| -36% | -$179K |
|
|
CBAY
75
DELISTED
Cymabay Therapeutics
CBAY
| $315K | 0.08% |
40,000
-10,000
| -20% | -$78.8K |
|